BROADWOOD CAPITAL INC Long-Term Concentrated

Location: New York, NY

CIK: 0001278387 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 16, 2020

Total Value: $1.272B (100.0% shares, 0.0% debt)

Holdings (7)

STAA STAAR SURGICAL CO 48.0%

Value $611M Shares 10,795,348 Est. Cost $8.21 Unrealized +556.0%

MNST MONSTER BEVERAGE CORP NEW 29.4%

Value $373M Shares 4,656,488 Est. Cost $22.71 Unrealized +74.0%

IWM ISHARES TR 12.9%

Value $164M Shares 1,095,000 Est. Cost $112.69 Unrealized —

AXON AXON ENTERPRISE INC 5.4%

Value $68.94M Shares 760,062 Est. Cost $27.50 Unrealized +216.4%

LCTX LINEAGE CELL THERAPEUTICS IN 2.5%

Value $31.85M Shares 34,005,379 Est. Cost $1.03 Unrealized -14.2%

— ONCOCYTE CORP 1.6%

Value $20.46M Shares 14,716,204 Est. Cost $3.13 Unrealized —

— AGEX THERAPEUTICS INC 0.2%

Value $2.428M Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	10,795,348	$611M	48.0%	$8.21	+556.0%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,656,488	$373M	29.4%	$22.71	+74.0%	COM	61174X109
IWM	ISHARES TR	1,095,000	$164M	12.9%	$112.69	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$68.94M	5.4%	$27.50	+216.4%	COM	05464C101
LCTX	LINEAGE CELL THERAPEUTICS IN	34,005,379	$31.85M	2.5%	$1.03	-14.2%	COM	53566P109
—	ONCOCYTE CORP	14,716,204	$20.46M	1.6%	$3.13	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$2.428M	0.2%	$2.99	—	COM	00848H108